23 employees
Senzagen offers animal-free testing of chemical compounds using genomics-based methodology for immunotoxicological assays.
2010
$2.5M
from 1 investors over 1 rounds
SenzaGen raised $2.5M on March 1, 2017
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)